Site contribution to the energy-optimized pharmacophores obtained from PDB complexes in bold from Table 1.

Tipus de document: info:eu-repo/semantics/other

DOI: 10.1371/journal.pone.0044971.t002

Publicacions relacionades: Guasch, L., Ojeda, M. J., González-Abuín, N., Sala, E., Cereto-Massagué, A., Mulero, M., Valls, C., Pinent, M., Ardévol, A., Garcia-Vallvé, S., & Pujadas, G. (2012). Identification of novel human dipeptidyl peptidase-iv inhibitors of natural origin (Part i): Virtual screening and activity assays. PLoS ONE, 7(9), e44971. https://doi.org/10.1371/journal.pone.0044971

Grup de recerca: Nutrigenòmica

Departament: Bioquímica i Biotecnologia

Autor: Guasch, Laura

Data alta repositori: 2012-09-12

Any de publicació de la dataset: 2012

Matèria: Bioquímica

Identificador del investigador: 0000-0003-4990-7765

DOI de la publicació relacionada: 10.1371/journal.pone.0044971

Idioma: en

Publicat per (editora): Universitat Rovira i Virgili (URV)

Drets d'accés: info:eu-repo/semantics/openAccess

Resum: Required and optional sites at the structure-based common pharmacophore are shown in bold and italics, respectively. The other sites are not part of the structure-based common pharmacophore. Data at the same raw for different PDB complexes indicate that the pharmacophore site is shared by these complexes.